A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer. (Q45919428)
Jump to navigation
Jump to search
scientific article published in August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer. |
scientific article published in August 2009 |
Statements
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer (English)
Thomas J Lynch
David Fenton
Vera Hirsh
David Bodkin
Edward L Middleman
Alberto Chiappori
Balazs Halmos
Reyna Favis
Hua Liu
William L Trepicchio
Frances A Shepherd
1 August 2009